The world’s only searchable, sortable database of CAR-T cell therapy companies that is publicly available.
Since the first historic CAR-T approvals in 2017, Kymriah (tisagenlecleucel), Yescarta (axicabtagene ciloleucel), Tecartus (brexucabtagene autoleucel), Breyanzi (lisocabtagene maraleucel), Abecma (idecabtagene vicleucel), and Relma-cel (relmacabtagene autoleucel) have reached commercialization.
These historic approvals have driven the CAR-T market to staggering new heights and fueled a frenzy of interest into CAR-T cell therapy development. To track the competitors who compose this rapidly expanding marketplace, BioInformant has released a global database of all known CAR-T cell therapy companies—currently 158 worldwide.
The "Global Database of CAR-T Cell Therapy Companies, 2022" features the following for all known market competitors:
- Company Name
- CAR-T Technology
- Disease Targets
- Description of CAR-T Involvement
- Country
- City / State
- Link to CAR-T Programs
- Company Website
It takes our team of analysts hours of research to uncover these CAR-T cell therapy companies from across the globe and requires the translation of sites and clinical trial programs across dozens of languages.
Thankfully, we have a talented, multilingual team who is up to the task of organizing all known CAR-T companies worldwide. Because we continuously update this database to reflect new competitors entering the marketplace, we are confident that you will find it to be invaluable resource.
Would you benefit from knowing the identities of all known CAR-T market competitors (158 total)?
Through tomorrow, January 7th only, you can claim this database for an unusual 50% off:
Happy New Year,
The BioInformant Team
p.s. Interested in other databases and reports to support your 2022 goals? Explore the BioInformant Shop.
And remember, all BioInformant products come with a Greater Than 100% Money Back Guarantee.
|
